Hesperidin induces anticancer effects on human prostate cancer cells via ROS-mediated necrosis like cell death.

CONCLUSION: Hesperidin was shown to selectively inhibit the growth of prostate cancer cells through apoptosis triggered by ROS generation. The results support its potential to act as lead molecule in anticancer drug design. PMID: 33455106 [PubMed - in process]
Source: Journal of B.U.ON. - Category: Cancer & Oncology Tags: J BUON Source Type: research